The hypertrophic cardiomyopathy (HCM) clinical trials team is interested in seeing how exciting new HCM drugs can help to improve the outcomes and quality of life for those living with the HCM disease.

Feel free to call or e-mail the Knight Cardiovascular Institute research team at 503-418-1964 or by emailing heartresearch@ohsu.edu. You will then be forwarded to the appropriate research team member who will be able to see if you qualify for any of the clinical trials being offered at OHSU. 

You can also find all the of heart failure clinical trials, that are currently enrolling patients, below.

Clinical Trial Name				Principal Investigator	Sub Investigators	Protocol Number
HCM Pilot Study: Hypertrophic Cardiomyopathy Pilot Study				Larisa Tereshchenko, MD PhD	Stephen Heitner, MD	IRB00015049
LIVE-HCM/LIVE-LQTS: Exercise in Genetic Cardiovascular Conditions				Stephen Heitner, MD	Charles Henrikson, MD / Eric Stecker, MD / Katherine Bischof, PA-C / Meghan Chirpich Mannello, CGC / Seshadri Balaji, MD / Sriram Ravi, MD / Thomas Dewland, MD	IRB00012026
MAVERICK-HCM: A Randomized, Double-blind, Pacebo-controlled, Concentration-guided, Exploratory Study of Mavacamten (MYK-461) in Patients with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction				Stephen Heitner, MD	Babak Nazer, MD / Erin Boehm, MD / Katherine Bischof, PA-C / Lidija Breznikar McGrath, MD / Michael Shapiro, MD / Mrinal Yadava, MD / Ryan Van Woerkom, MD / Steven Mansoor, MD / Thomas Dewland, MD / Vaughn Tuchy, MD	IRB00018173